Kallikreins are overexpressed in ovarian, breast and prostatic carcinomas and that some may be important new biomarkers for diagnosis and monitoring of many cancer types (9, 10).The overexpression of kallikreins in malignant tumors has been linked with both favorable and poor patient prognosis (6). This evidence concerns the gene KLK4 and cancer.